Dedicated to being a pioneer for innovation in new drug development.
TaiRx, Inc. 2023-05-02T15:52:23+00:00

Information Related to Clinical Trials

TaiRx’s novel anti-cancer drug CVM-1118 is currently in Phase II clinical program.

Clinical Trial of CVM-1118 on Neuroendocrine Tumors

CVM-005

  • Center for Drug Evaluation, Taiwan:(Click here)
  • ClinicalTrials.gov:(Click here)

Clinical Trial of CVM-1118 on Hepatocellular Cancer

CVM-008

  • Center for Drug Evaluation, Taiwan:(Click here)
  • ClinicalTrials.gov:(Click here)

If you would like to learn more information regarding the clinical trials, please contact the nearest clinical trial center.

News